Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Cell biology of heart failure 

Cell biology of heart failure
Chapter:
Cell biology of heart failure
Author(s):

Kenneth B. Margulies

and J. Eduardo Rame

DOI:
10.1093/med/9780198734871.003.0002
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 23 January 2021

In many etiologies of heart failure there is a reduction of the normal number of cardiac myocotes, and the syndrome is consistently associated with both qualitative and quantitative changes in these cells. This chapter describes the triggers, phenomena, and mechanisms associated with the transitions away from normal cardiac myocyte structure and function during pathological remodeling of the heart. Morphological adaptations of cardiac myocytes, the regulation of cardiac contractility, cardiac metabolism, and alternative cell death pathways activated in failing hearts are considered. The reversibility of cardiac myocyte hypertrophy and dysfunction that has been demonstrated in in recent years is also highlighted. These reverse remodeling phenomena demonstrate the substantial plasticity of the severely failing heart, providing insights into factors driving and sustaining pathological adaptations and attesting to the potential benefit of importance of therapeutic interventions targeting the failing heart.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.